IVERIC bio
About:
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Website: https://ivericbio.com
Top Investors: Hercules Capital, Sofinnova Investments, Novo Holdings, SV Health Investors, Silicon Valley Bank
Description:
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.
$858M
$100M to $500M
Princeton, New Jersey, United States
2007-01-01
Samir Patel
101-250
2022-11-30
Public
© 2025 bioDAO.ai